Lupin Limited (NSE:LUPIN)
India · Delayed Price · Currency is INR 2,055.30
+2.40 (0.12%)
Nov 14, 2025, 3:30 PM IST
Lupin Market Cap
Lupin has a market cap or net worth of 937.68 billion as of November 14, 2025. Its market cap has decreased by -3.51% in one year.
Market Cap
937.68B
Enterprise Value
937.99B
Revenue
247.51B
Ranking
n/a
PE Ratio
21.68
Stock Price
2,055.30
Market Cap Chart
Since September 29, 1999, Lupin's market cap has increased from 998.14M to 937.68B, an increase of 93,842.72%. That is a compound annual growth rate of 29.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2025 | 937.68B | -12.58% |
| Dec 31, 2024 | 1.07T | 78.05% |
| Dec 29, 2023 | 602.42B | 80.75% |
| Dec 30, 2022 | 333.29B | -22.86% |
| Dec 31, 2021 | 432.05B | -2.46% |
| Dec 31, 2020 | 442.95B | 27.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.12T |
| Divi's Laboratories | 1.74T |
| Cipla | 1.22T |
| Apollo Hospitals Enterprise | 1.08T |
| Zydus Lifesciences | 954.31B |
| Mankind Pharma | 916.53B |
| Fortis Healthcare | 745.07B |
| Alkem Laboratories | 679.07B |